SUPPLEMENTARY INFORMATION:

Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: Alzheimer's disease and related dementias, department initiatives, clinical care, and innovation.

Procedure and Agenda: The events will be webcast at www.hhs.gov/​live and video recordings will be added to the National Alzheimer's Project Act website ^[1] when available after the meeting. These events are open to the public.

Public Attendance and Registration: To register for the Summit, the Advisory Council meeting, or both, please complete the registration form by Monday, October 12: forms.cloud.microsoft/​g/​QLYF2dvykW. In-person seating for members of the public is limited and will be available on a first-come, first-served basis. Submitting the registration form does not reserve or guarantee a seat. The names of expected in-person attendees will be provided to HHS security. Any interested member of the public who is a non-U.S. citizen should include this information on the registration form to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and entrance to Federal buildings may change without notice. If you wish to make a public comment, you must indicate on your registration form. Please note that individuals entering HHS owned, leased, or operated facilities must present a REAL ID compliant credential or another federally approved form of identification. Below is the list of acceptable forms of ID.

• State-issued Enhanced Driver's License
• U.S. passport ^[2]
• U.S. passport card ^[3]
• DHS trusted traveler cards (Global Entry, NEXUS, SENTRI, FAST)
• U.S. Department of Defense ID, including IDs issued to dependents
• Permanent resident card
• Border crossing card

>• An acceptable photo ID issued by a federally recognized ^[4] Tribal Nation/Indian Tribe, including Enhanced Tribal Cards (ETCs)

• HSPD-12 PIV card
• Foreign government-issued passport
• Canadian provincial driver's license or Indian and Northern Affairs Canada card
• Transportation worker identification credential
• U.S. Citizenship and Immigration Services Employment Authorization Card (I-766)
• U.S. Merchant Mariner Credential
• Veteran Health Identification Card (VHIC)

Comments: Time will be allocated on the agenda to hear public comments from 3:30 p.m. to 3:55 p.m. Oral comments will be limited to two (2) minutes per individual. Individuals who wish to provide an oral public comment must register using the registration form no later than Monday, October 12: forms.cloud.microsoft/​g/​QLYF2dvykW.

Registered commenters participating virtually will receive a meeting link and dial-in number and may use either option to join the meeting. Individuals may also request that NAPA staff read their comments during the public comment session. To make this request, please select the applicable response on the registration form and email the comment to napa@hhs.gov with the subject line “October 19 Public Comments Reading Request.” Comments to be read by NAPA staff must be received by Monday, October 12. Note: There may be a 30-45 second delay in the livestream video presentation of the meeting. For this reason, if you have pre-registered to submit a public comment, it is important to connect to the meeting by 2:55 p.m., to ensure that you do not miss your name and allotted time when called. If you miss your name and allotted time to speak, you may not be able to make your public comment. All participant audio lines will be muted for the duration of the meeting and only unmuted by the Host at the time of the participant's public comment. Should you have questions during the meeting, email napa@hhs.gov and someone will respond to your message as quickly as possible. To ensure accuracy, please submit a written copy of oral comments for the record by emailing napa@hhs.gov by Wednesday, October 21, 2026. Please attach the comments as a Microsoft Word (.docx) file so they can be compiled for publication. You may also attach a PDF copy for reference, but a Word version is required. These comments will be shared on the website and reflected in the meeting summary.

• In lieu of oral comments, formal written comments may be submitted for the record by emailing them tonapa@hhs.gov or mailing them to Maria- ( printed page 63295) Theresa Okafor, Ph.D., MCG, Designated Federal Officer, OASPE, 200 Independence Avenue SW, Room 438F.7, Washington, DC 20201 by Wednesday, October 21, 2026. Those submitting written comments should identify themselves and any relevant organizational affiliations.

Authority:42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer's Project Act. The panel is governed by provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees.

91 FR 63294